Hossein Borghaei, DO
Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111
Video: Hossein Borghaei, DO
Chief, Thoracic Medical Oncology
Director, Lung Cancer Risk Assessment
American Board of Internal Medicine;
National Board of Osteopathic Medical Examiners;
After completing my fellowship at Fox Chase, I joined the medical staff in 2004. I have a special interest in lung cancers. I believe in offering my patients the newest therapies available, which include antibodies and other immune-based therapies.
My laboratory research is focused on the production of monoclonal antibodies against novel targets in tumor blood vessels. These antibodies have the potential to be used in the treatment of several types of cancer. In addition, my other research interest is to learn how the body's immune system plays a role in the fight against cancer.
Philadelphia College of Osteopathic Medicine, 1996
MS in Microbiology and Immunology, Temple Medical School, Philadelphia, Pennsylvania
Graduate Hospital, Philadelphia, Pa.
Hematology-Oncology, Fox Chase Cancer Center, Chief Fellow
Monoclonal Antibody; Targeted Therapy; Immunotherapy Cancer Vaccine